"Rising costs of labour and raw materials has become a dominant topic of 2022. Inflation is expected to put some pressure on the profit growth of pharma businesses, resulting in reduced investment ...
About 63 per cent of healthcare and pharmaceutical industry professionals in North America expected a disruption to digitalisation initiatives in their business units due to inflation. Digitalisation ...
London: A total of 58 per cent healthcare industry professionals globally believe that digital transformation initiatives—involving the implementation of emerging technologies such as artificial ...